Free Trial

Ilmarinen Mutual Pension Insurance Co Cuts Holdings in Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Ilmarinen Mutual Pension Insurance Co cut its Synopsys stake by 20.1% in the fourth quarter, selling 10,492 shares and leaving it with 41,807 shares valued at about $19.6 million.
  • Synopsys reported strong fiscal Q2 results, with EPS of $3.35 and revenue of $2.28 billion, both ahead of estimates; revenue jumped 41.9% from a year earlier.
  • The company also raised FY2026 guidance, but the stock still fell 8.6% as investors weighed near-term concerns, even as several analysts increased their price targets.
  • Interested in Synopsys? Here are five stocks we like better.

Ilmarinen Mutual Pension Insurance Co decreased its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 20.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,807 shares of the semiconductor company's stock after selling 10,492 shares during the quarter. Ilmarinen Mutual Pension Insurance Co's holdings in Synopsys were worth $19,638,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Synopsys in the fourth quarter valued at approximately $28,000. Oakworth Capital Inc. increased its holdings in shares of Synopsys by 3,700.0% in the 4th quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company's stock valued at $36,000 after acquiring an additional 74 shares during the last quarter. KERR FINANCIAL PLANNING Corp purchased a new position in shares of Synopsys in the 3rd quarter valued at about $38,000. WealthCollab LLC increased its holdings in shares of Synopsys by 110.8% in the 3rd quarter. WealthCollab LLC now owns 78 shares of the semiconductor company's stock valued at $38,000 after acquiring an additional 41 shares during the last quarter. Finally, N.E.W. Advisory Services LLC increased its holdings in shares of Synopsys by 128.6% in the 4th quarter. N.E.W. Advisory Services LLC now owns 80 shares of the semiconductor company's stock valued at $38,000 after acquiring an additional 45 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.

Synopsys Stock Down 8.6%

Shares of NASDAQ SNPS opened at $480.64 on Friday. The stock has a market cap of $92.07 billion, a PE ratio of 111.26, a price-to-earnings-growth ratio of 4.31 and a beta of 1.25. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 52-week low of $376.18 and a 52-week high of $651.73. The business has a 50-day moving average price of $458.59 and a 200 day moving average price of $454.30.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.91%. The company's revenue for the quarter was up 41.9% compared to the same quarter last year. During the same period last year, the firm posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts forecast that Synopsys, Inc. will post 10.28 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on SNPS. Citigroup increased their price objective on Synopsys from $600.00 to $610.00 and gave the company a "buy" rating in a report on Thursday. Rosenblatt Securities increased their price objective on Synopsys from $530.00 to $575.00 and gave the company a "buy" rating in a report on Tuesday. Robert W. Baird set a $558.00 price objective on Synopsys in a report on Thursday. Needham & Company LLC reiterated a "buy" rating and issued a $580.00 price objective on shares of Synopsys in a report on Thursday. Finally, Morgan Stanley increased their price objective on Synopsys from $480.00 to $525.00 and gave the company an "equal weight" rating in a report on Thursday. Nine analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $563.81.

Read Our Latest Analysis on SNPS

Synopsys News Summary

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Synopsys reported fiscal Q2 adjusted EPS of $3.35, beating estimates, on revenue of $2.28 billion, also ahead of expectations, with revenue up 41.9% year over year.
  • Positive Sentiment: The company lifted full-year FY2026 guidance, signaling continued demand for AI chip design software and stronger-than-expected momentum across the business.
  • Positive Sentiment: Synopsys reached a governance agreement with Elliott Investment Management and added Jesse Cohn to the board, which investors may view as a step toward better capital allocation and execution.
  • Positive Sentiment: Several analysts raised price targets after the earnings release, reflecting confidence in the company’s longer-term AI and semiconductor design opportunity.
  • Neutral Sentiment: Synopsys also showcased new AI-powered design flows and IP support for Samsung Foundry processes, reinforcing its position in advanced chip design.
  • Negative Sentiment: The stock is reacting negatively because investors may be worried that strong results are not enough to offset near-term business mix issues, including softness in chip IP and integration complexity tied to Ansys.

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines